{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:09:09Z","timestamp":1762099749637,"version":"3.40.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[1999,9]]},"DOI":"10.1023\/a:1009027315912","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T18:49:18Z","timestamp":1040582958000},"page":"201-204","source":"Crossref","is-referenced-by-count":12,"title":["Long-term remission of Crohn's disease treated with thalidomide: A seminal case report"],"prefix":"10.1007","volume":"3","author":[{"given":"Steven J.","family":"Fishman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil R.","family":"Feins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"D'Amato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judah","family":"Folkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"261858_CR1","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0140-6736(61)90927-8","volume":"2","author":"WG. McBride","year":"1961","unstructured":"McBride WG. Thalidomide and congenital abnormalities. [Letter] Lancet 1961; 2: 1358.","journal-title":"Lancet"},{"key":"261858_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0140-6736(62)92665-X","volume":"i","author":"W. Lenz","year":"1962","unstructured":"Lenz W. Thalidomide and congenital abnormalities. Lancet 1962; i: 45.","journal-title":"Lancet"},{"key":"261858_CR3","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","volume":"91","author":"RJ D'Amato","year":"1994","unstructured":"D'Amato RJ, Loughnan MS, Flynn E, Folkman J. Thalidomide is an angiogenesis inhibitor. Proc Natl Acad Sci USA 1994; 91: 4082\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"unstructured":"Fine HA, Loeffler JS, Kyritsis A et al. A phase II trial of the anti-angiogenic agent, thalidomide in patients with recurrent high-grade gliomas. Proc Am Soc Clin Oncol 1997; 16 (Abstr #1372).","key":"261858_CR4"},{"key":"261858_CR5","first-page":"318a","volume":"92","author":"S Singal","year":"1998","unstructured":"Singal S, Mehta J, Eddlemon P et al. Marked anti-tumor effect from anti-angiogenesis (AA) therapy with thalidomide (T) in high risk refractory multiple myeloma (MM). Blood 1998; 92: 318a (Abstr 1306, Suppl 1).","journal-title":"Blood"},{"key":"261858_CR6","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(94)92686-7","volume":"343","author":"P Jakeman","year":"1994","unstructured":"Jakeman P, Smith WLS. Thalidomide in leprosy reaction. Lancet 1994; 343: 432\u20133.","journal-title":"Lancet"},{"key":"261858_CR7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","volume":"128","author":"V Hamuryundan","year":"1998","unstructured":"Hamuryundan V, Mat C, Saip S et al. Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998; 128: 443\u201350.","journal-title":"Ann Intern Med"},{"key":"261858_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1365-2133.1983.tb04601.x","volume":"108","author":"CR Lovell","year":"1983","unstructured":"Lovell CR, Hawk JLM, Calnan CD, Magnus IA. Thalidomide in actinic prurigo. Br J Dermatol 1983; 108: 467\u201371.","journal-title":"Br J Dermatol"},{"key":"261858_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1365-2133.1983.tb04600.x","volume":"108","author":"J Knop","year":"1983","unstructured":"Knop J, Bonsmann G, Happle R et al. Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus. Br J Dermatol 1983; 108: 461\u20136.","journal-title":"Br J Dermatol"},{"key":"261858_CR10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/sj.bmt.1701138","volume":"21","author":"A Rovelli","year":"1998","unstructured":"Rovelli A, Arrigo C, Nesi F et al. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children. Bone Marrow Transplant 1998; 21: 577\u201381.","journal-title":"Bone Marrow Transplant"},{"key":"261858_CR11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2141.1991.tb04377.x","volume":"78","author":"D Heney","year":"1991","unstructured":"Heney D, Norfolk DR, Wheeldon J et al. Thalidomide treatment for chronic graft-versus-host disease. Br J Haematol 1991; 78: 23\u20137.","journal-title":"Br J Haematol"},{"key":"261858_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000187978","volume":"67","author":"SRB Silva","year":"1994","unstructured":"Silva SRB, Viana PCF, Lugon NV et al. Thalidomide for the treatment of uremic pruritus: A crossover randomized double-blind trial. Nephron 1994; 67: 270\u20133.","journal-title":"Nephron"},{"key":"261858_CR13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1056\/NEJM199207163270319","volume":"327","author":"J Ryan","year":"1992","unstructured":"Ryan J, Colman J, Pedersen J, Benson E. Thalidomide to treat esophageal ulcer in AIDS. N Engl J Med 1992; 327: 208\u20139.","journal-title":"N Engl J Med"},{"key":"261858_CR14","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJM199705223362103","volume":"336","author":"JM Jacobson","year":"1997","unstructured":"Jacobson JM, Greenspan JS, Spritzler J et al. For the National Institute of Allergy and Infection Diseases AIDS Clinical Trial Group. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency viral infection. N Engl J Med 1997; 336: 1487\u201393.","journal-title":"N Engl J Med"},{"key":"261858_CR15","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1136\/bmj.1.6166.792","volume":"1","author":"MFR Waters","year":"1979","unstructured":"Waters MFR, Laing ABG, Ambikapathy A, Lennard-Jones JE. Treatment of ulcerative colitis with thalidomide. BMJ 1979; 1: 792.","journal-title":"BMJ"},{"key":"261858_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2796.1990.tb00253.x","volume":"228","author":"H. Larsson","year":"1990","unstructured":"Larsson H. Case report. Treatment of severe colitis in Behcet's syndrome with thalidomide (CG-217). J Intern Med 1990; 228: 405\u20137.","journal-title":"J Intern Med"},{"key":"261858_CR17","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(05)64206-7","volume":"350","author":"AR Wettstein","year":"1997","unstructured":"Wettstein AR, Meagher AP. Thalidomide in Crohn's Disease [Letter]. Lancet 1997; 350: 1445\u20136.","journal-title":"Lancet"},{"key":"261858_CR18","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/00005176-199708000-00032","volume":"25","author":"EB Odeka","year":"1997","unstructured":"Odeka EB, Miller V. Thalidomide in oral Crohn's disease refractory to conventional medical treatment [Letter]. J Pediatr Gastroenterol Nutr 1997; 25: 250\u20131.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"261858_CR19","first-page":"821","volume-title":"Inflammation: Basic Principles and Clinical Correlates","author":"J Folkan","year":"1992","unstructured":"Folkan J, Brem H. Angiogenesis and inflammation. In: Gallin JL, Goldstein IM, Snyderman R (eds) Inflammation: Basic Principles and Clinical Correlates. Second edition. New York: Raven Press 1992; Chapter 40, 821\u201339.","edition":"Second edition"},{"key":"261858_CR20","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S0140-6736(89)91078-7","volume":"2","author":"AJ Wakefield","year":"1989","unstructured":"Wakefield AJ, Dhillon AP, Rowles PM et al. Pathogenesis of Crohn's disease: Multifocal gastrointestinal infarction. Lancet 1989; 2: 1057\u201362.","journal-title":"Lancet"},{"key":"261858_CR21","first-page":"3783","volume":"42","author":"A Bousvaros","year":"1997","unstructured":"Bousvaros A, Zurakowski D, Fishman SJ et al. Serum basic fibroblast growth factor in pediatric Crohn's disease: Implications for wound healing. Dig Dis Sci 1997; 42: 3783\u20136.","journal-title":"Dig Dis Sci"},{"key":"261858_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1023\/A:1026635308127","volume":"44","author":"A Bousvaros","year":"1999","unstructured":"Bousvaros A, Leichtner A, Zurakowski D et al. Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease. Dig Dis Sci 1999; 44: 424\u201330.","journal-title":"Dig Dis Sci"},{"key":"261858_CR23","first-page":"A1194","volume":"112","author":"CT Taylor","year":"1997","unstructured":"Taylor CT, Lisco SJ, Fishman SJ, Colgan SP. T84 intestinal epithelial cells express a functional VEGF receptor: Potential role in the regulation of ion transport. Gastroenterology 1997; 112: A1194.","journal-title":"Gastroenterology"},{"unstructured":"Spalinger JH, Patriquin H, Miron M-C et al. Doppler sonography in Crohn's disease: Intestinal vessel density reflects disease activity. 1999; in press.","key":"261858_CR24"},{"key":"261858_CR25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1084\/jem.173.3.699","volume":"173","author":"EP Sampaio","year":"1991","unstructured":"Sampaio EP, Sarno AN, Galilly R et al. Thalidomide selectively inhibits tumor necrosis factor a production by stimulated human monocytes. J Exp Med 1991; 173: 699\u2013703.","journal-title":"J Exp Med"},{"key":"261858_CR26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/gut.32.8.913","volume":"32","author":"SH Murch","year":"1991","unstructured":"Murch SH, Lamkin VA, Savage MO et al. Serum concentrations of tumour necrosis factor-alpha in childhood chronic inflammatory bowel disease. Gut 1991; 32: 913\u20137.","journal-title":"Gut"},{"key":"261858_CR27","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1136\/gut.34.12.1705","volume":"34","author":"SH Murch","year":"1994","unstructured":"Murch SH, Braegger CP, Walter-Smith JA, MacDonald TT. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 1994; 34: 1705\u20139.","journal-title":"Gut"},{"key":"261858_CR28","first-page":"177","volume":"13","author":"CL. Crawford","year":"1994","unstructured":"Crawford CL. Use of thalidomide in leprosy. Adverse Drug React Toxicol Rev 1994; 13: 177\u201392.","journal-title":"Adverse Drug React Toxicol Rev"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1009027315912.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1009027315912\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1009027315912.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T06:03:33Z","timestamp":1747461813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1009027315912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["261858"],"URL":"https:\/\/doi.org\/10.1023\/a:1009027315912","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"type":"print","value":"0969-6970"},{"type":"electronic","value":"1573-7209"}],"subject":[],"published":{"date-parts":[[1999,9]]}}}